Cidara Therapeutics Files For IPO

San Diego-based Cidara Therapeutics, a biotechnology company developing anti-fungal medicines, said Monday that it has filed for an IPO. Cidara said it is looking to raise up to $69M in an IPO on the NASDAQ Global Market as CDTX. The IPO is being underwritten by Jefferies, Leerink Partners, Wedbush PacGrow Life Sciences, Needham & Company, and BTIG. Cidara is backed by 5AM Ventures, Fidelity Management, InterWest, Frazier Healthcare Ventures, and Seachaid Pharmaceuticals.